老年类风湿关节炎相关间质性肺病的患病率、发病率及病因特异性死亡率
这项基于美国Medicare索赔数据的全国性队列研究纳入509 787例老年RA患者,基线时2.0%存在RA-ILD,随访期间2.6%新发RA-ILD。RA-ILD患者总死亡风险显著升高(HR 1.66),呼吸系统死亡(sdHR 4.39)和癌症死亡(sdHR 1.56)风险亦增加。
要点
- 老年RA患者中RA-ILD总体患病或发病接近5%。
- RA-ILD与总死亡率、呼吸系统死亡及癌症死亡风险升高相关。
- 呼吸系统死亡风险升高最为显著(sdHR 4.39)。
核心结论
- 在老年RA患者中,RA-ILD与总死亡、呼吸系统死亡和癌症死亡风险升高相关,且这些超额死亡不能由已测量因素解释。
研究设计与样本
- 全国性队列研究,使用2008-2017年Medicare索赔数据(A、B、D部分),纳入509 787例RA患者(平均年龄72.6岁,76.2%女性)。
- RA和RA-ILD均采用验证算法识别,RA-ILD相对于基线分为患病或新发。
- 采用多变量Cox回归比较总死亡率,采用Fine和Gray竞争风险模型估计病因特异性死亡风险。
主要发现
- 基线时10 306例(2.0%)存在RA-ILD,随访期间13 372例(2.6%)新发RA-ILD,总随访1 873 127人年(中位3.0年/人)。
- 随访期间RA-ILD患者死亡比例为38.7%,而无ILD的RA患者为20.7%。
- 多变量调整后,RA-ILD总死亡HR为1.66(95% CI 1.60, 1.72)。
- 考虑竞争风险后,RA-ILD呼吸系统死亡sdHR为4.39(95% CI 4.13, 4.67),癌症死亡sdHR为1.56(95% CI 1.43, 1.71)。
临床怎么用
- 对老年RA患者应警惕RA-ILD的发生,因其与总死亡、呼吸系统死亡及癌症死亡风险显著升高相关。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: We aimed to investigate the prevalence, incidence and cause-specific mortality of RA-associated interstitial lung disease (RA-ILD) among older US patients with RA. METHODS: We performed a nationwide cohort study using Medicare claims data (parts A, B and D for 2008-2017). RA was identified with a validated algorithm using RA diagnosis codes and DMARD prescription. RA-ILD was identified with a validated algorithm using ILD diagnosis codes by a rheumatologist/pulmonologist. RA-ILD was categorized as prevalent or incident relative to the initial RA observation (baseline/index date). We compared the total mortality of RA-ILD to RA without ILD using multivariable Cox regression, adjusting for baseline covariates. For cause-specific mortality, Fine and Gray subdistribution hazard ratios (sdHRs) were estimated to handle competing risks of alternative mortality causes. RESULTS: Among 509 787 RA patients (mean age 72.6 years, 76.2% female), 10 306 (2.0%) had prevalent RA-ILD at baseline. After baseline, 13 372 (2.6%) developed RA-ILD during 1 873 127 person-years of follow-up (median 3.0 years/person). During follow-up, 38.7% of RA-ILD patients died compared with 20.7% of RA patients without ILD. After multivariable adjustment, RA-ILD had an HR of 1.66 (95% CI 1.60, 1.72) for total mortality. Accounting for competing risk of other causes of death, RA-ILD had an sdHR of 4.39 (95% CI 4.13, 4.67) for respiratory mortality and an sdHR of 1.56 (95% CI 1.43, 1.71) for cancer mortality compared with RA without ILD. CONCLUSIONS: RA-ILD was present or developed in nearly 5% of patients in this nationwide study of older patients with RA. Compared with RA without ILD, RA-ILD was associated with excess total, respiratory and cancer mortality that was not explained by measured factors.
引用
- Sparks JA, Jin Y, Cho SK, et al. Prevalence, incidence and cause-specific mortality of rheumatoid arthritis-associated interstitial lung disease among older rheumatoid arthritis patients. Rheumatology (Oxford). 2021. PMID: 33462611. doi:10.1093/rheumatology/keaa836
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。